ASML Fair Value Rises Slightly Amid Mixed Analyst Target Revisions
Yahoo Finance ·
The calculated fair value for ASML has advanced from €2,051.09 to €2,107.73, indicating a slightly elevated valuation baseline following recent evaluations. According to updates released on October 23, 2026, expert price objectives present a mixed picture with both upward and downward adjustments. Bank of America continues to endorse ASML as a top pick, previously raising its target to €2,557, while Citi elevated its target to €2,300. JPMorgan maintained an Overweight rating alongside a $2,350 target, and Goldman Sachs included the stock in its European Conviction List. Conversely, several institutions trimmed their targets due to lower sector multiples. Key financial assumptions have evolved, with projected revenue growth shifting from 23.46% to 22.63% and net profit margin expectations improving from 38.90% to 40.54%. Furthermore, the future P/E multiple adjusted from 39.0x to 34.7x, and the discount rate moved from 9.47% to 9.44%, reflecting ongoing debates over the company's long-term market potential.
AI 시장 분석
ASML's fair value has been revised upward from 2,051.09 EUR to 2,107.73 EUR, with major institutions like BofA, Citi, and Goldman Sachs maintaining positive price targets. Net profit margin estimates rose from 38.90% to 40.54%, while the forward P/E ratio adjusted from 39.0x to 34.7x. Investors should focus on long-term growth driven by EUV demand and the expansion of AI-linked semiconductor production.
상승 영향
- Semiconductors — ASML's fair value was raised to 2,107.73 EUR and major institutions like BofA and Goldman Sachs maintained high price targets, highlighting the visibility of EUV and DRAM orders.
- AI — Analysis that the expansion of AI-linked chip production capacity and the adoption of the High-NA platform will lead to increased equipment shipments and service revenue acts as a positive catalyst.
하락 영향
- Semiconductors — Some investment banks lowered price targets based on declining sector multiples, raising cautious views regarding valuation burdens.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 31% · Bearish (Short) 69%
350 participants
Related News
- US FDA Approves Novo's Once-Weekly Insulin for Pediatric Type 2 Diabetes
- Arm Just Dropped 19% in a Month. Is It Time to Sell, or Load Up?
- Why Bloom Energy Stock Plunged Despite Record Earnings and Strong AI Demand
- Update: US Equity Indexes Mixed as Technology Attempts Recovery Amid Surging Crude Oil
- Behind Elon Musk's $1B Skydance Investment and Its Timing
- Strong Azure Growth and Cash Flow Discipline Strengthen Microsoft
